Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 9/20 | 0.32 |
| ▸ | PPARA | Q07869 | 9/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.32 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | TNF | P01375 | 1/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.31 |
| ▸ | CHRNG | P07510 | 1/20 | 0.31 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23614708 | 0.96 | CA12 (0.36) | CA12CA1CA2CA9PPARG | |
| SCHEMBL23614897 | 0.92 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL23621718 | 0.92 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL23614155 | 0.92 | CA12 (0.33) | CA12CA1CA2CA9PPARG | |
| SCHEMBL23614211 | 0.91 | CHRNB4 (0.32) | CA12CA1CA2CA9PPARG | |
| SCHEMBL23614841 | 0.89 | CA12 (0.35) | CA12CA1CA2CA9PPARG | |
| SCHEMBL23614711 | 0.89 | CA12 (0.37) | CA12CA1CA2CA9PPARG | |
| SCHEMBL23614586 | 0.89 | CA12 (0.37) | CA12CA1CA2CA9PPARG | |
| SCHEMBL23614641 | 0.89 | CA12 (0.35) | CA12CA1CA2CA9PPARG | |
| SCHEMBL23621600 | 0.89 | CA12 (0.37) | CA12CA1CA2CA9PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11203584-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2021-12-21 | — | — | US | disclosed |
| US-20210206741-A1 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2021-07-08 | — | — | US | disclosed |
| EP-3845522-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | Shaanxi Lighte Optoelectronics Material Co., Ltd. (CN) | 2021-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206741-A1 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | CA12 1315/4885CA1 684/4885CA2 1517/4885 |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | CA12 1315/4885CA1 684/4885CA2 1517/4885 |
| US-11203584-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | CA12 1315/4885CA1 684/4885CA2 1517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.